LESLIE ENGLE: Open Payments
NPI 1285326017 · RICHMOND, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,495 in 87 payments from 28 companies in 2025. Trend: 2023 $113 · 2024 $1,441 · 2025 $1,495
Food & beverage: $1,425Education: $70
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 25 | $255 |
| ABBVIE INC. | 8 | $170 |
| Eisai Inc. | 5 | $124 |
| Adaptive Biotechnologies Corporation | 4 | $97 |
| PFIZER INC. | 5 | $94 |
| GENZYME CORPORATION | 3 | $71 |
| Merck Sharp & Dohme LLC | 4 | $70 |
| Janssen Biotech, Inc. | 4 | $70 |
| Regeneron Healthcare Solutions, Inc. | 3 | $67 |
| AstraZeneca Pharmaceuticals LP | 3 | $60 |
Products named: VENCLEXTA, Lenvima, clonoSEQ, KISQALI, LUTATHERA, SARCLISA, LIBTAYO, PADCEV.
Industry payments across IN — which companies pay providers there.
